MARC details
| 000 -LEADER |
|---|
| fixed length control field |
02022nam a2200277Ia 4500 |
| 000 - LEADER |
|---|
| fixed length control field |
03692naaa 00757uu |
| 001 - CONTROL NUMBER |
|---|
| control field |
https://directory.doabooks.org/handle/20.500.12854/68320 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20211222133724.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
211013s9999 xx 000 0 und d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783039438716 |
| 024 ## - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.3390/books978-3-03943-872-3 |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
dc |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
Advance in Gluten-Free Diet |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Basel, Switzerland |
| Name of publisher, distributor, etc. |
MDPI - Multidisciplinary Digital Publishing Institute |
| Date of publication, distribution, etc. |
2021 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 electronic resource (110 p.) |
| 506 ## - RESTRICTIONS ON ACCESS NOTE |
|---|
| Terms governing access |
Open Access |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
The only effective and safe treatment of celiac disease (CD) is a lifelong, strict exclusion of gluten, the so-called gluten-free diet (GFD). As a consequence, strict adherence to the GFD is highly successful and useful to achieve optimal control of symptoms in celiac patients, although, sometimes, nutritional problems can persist despite a strict exclusion of gluten. However, following a strict GFD is not easy and an updated quality assessment of available products is needed for further improvement in gluten-free product development. Similar to CD, GFD is the common dietary approach in non-celiac gluten/wheat sensitivity (NCGWS). NCGWS is another common gluten-related disorder without the diagnostic features of CD. Increasing interest in the association and interaction between irritable bowel syndrome (IBS), functional dyspepsia, and gluten-related disorders can expand our knowledge and understanding of the management of these disorders. In this respect, GFD is considered a therapeutic option in IBS and functional digestive disorders. New insights into the GFD are an exciting scientific challenge for researchers. |
| 540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
|---|
| Terms governing use and reproduction |
Creative Commons |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
irritable bowel syndrome |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Paolo, Usai-Satta |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Paolo, Usai-Satta |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://directory.doabooks.org/handle/20.500.12854/68320">https://directory.doabooks.org/handle/20.500.12854/68320</a> |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://mdpi.com/books/pdfview/book/3330">https://mdpi.com/books/pdfview/book/3330</a> |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="www.oapen.org">www.oapen.org</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
E-Book |
